Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2017

View Archived Issues

Improved respiratory pathology associated to Pompe disease with the new vector AAV-B1-GAA

Complement factor B targeted with IONIS-FB-LRX for age-related macular degeneration

Otsuka and Teva enter licensing agreement for fremanezumab in Japan

Phase III NEURO-TTR study of inotersen meets both primary endpoints

Phase I results for tetravalent dengue vaccine TV-003 in flavivirus-experienced subjects

Novel nickel catalyst transforms unrefined hydrocarbons and carbon dioxide into valuable fatty acids

FDA accepts Aerie Pharmaceuticals' NDA for Rhopressa

Biogen acquires Cirara from Remedy Pharmaceuticals

Cytokinetics' CK-2127107 named FDA orphan drug for SMA

Quadruplex sgRNAs/saCas9 AAV gene therapy results in successful HIV-1 provirus excision in vivo

FDA grants breakthrough therapy designation to entrectinib

Imara's IMR-687 awarded FDA rare pediatric disease designation

Immunomic Therapeutics and Annias enter license agreement for cancer immunotherapy technology

Development of cell-mediated gene therapy Invossa updated at ASCGT

New prophylactic vaccine against influenza A and B viruses

Takeda splits off part of its pharmaceutical research businesses to new company

Improved polymerase-1 inhibitor RAM-589.555 synthesized for multiple sclerosis treatment

Advaxis reports data from phase I study of axalimogene filolisbac

Enterin initiates phase I/IIa study of synthetic squalamine derivative for Parkinson's disease

Glenmark Pharmaceuticals cleared to begin phase I study of GBR-1342

Boehringer Ingelheim plans phase II trial for PXS-4728A in second indication

VV-2003, an ORAI1 calcium channel inhibitor for the treatment of colitis

BiomX raises funds to support development of mircrobiome therapeutics

Formation Biologics begins phase I/IIa trial of AVID-100

Amicus Therapeutics reports results from phase I/II study in Pompe disease

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...